Risk factors for perforated marginal ulcers following pancreaticoduodenectomy and prospective analysis of marginal ulcer development.
Pancreaticoduodenectomy (PD)
marginal ulcer
pancreas
perforated marginal ulcer (PMU)
pylorus preserving Whipple’s procedure
Journal
Gland surgery
ISSN: 2227-684X
Titre abrégé: Gland Surg
Pays: China (Republic : 1949- )
ID NLM: 101606638
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
entrez:
12
3
2021
pubmed:
13
3
2021
medline:
13
3
2021
Statut:
ppublish
Résumé
Perforated marginal ulcers (PMUs) are a feared long-term complication following pancreaticoduodenectomy (PD), which always require relaparotomy compared to marginal ulcers. First, we performed a retrospective chart review for all patients who underwent PD from 2007-2016 to identify incidence and risk factors associated with PMUs. Second, we analyzed follow up gastroscopies in all patients undergoing PD from 2007-2011 to identify the overall incidence of marginal ulcers. A total of 725 patients underwent PD in the retrospective study period. 17 patients (2.3%) suffered from PMU at a median postoperative time of 13 months. These patients were significantly younger (median age: 49 vs. 62 years; P=0.02) and suffered most often from chronic pancreatitis (P<0.001). Smoking and alcohol consumption were significantly more common (P=0.01 and P=0.023). An elevated level of carcinoembryonic antigen and chronic pancreatitis were identified as independent risk factors. Overall, 373 patients were enrolled for prospective analysis. Marginal ulcers occurred in 5-5.9% over a postoperative period of 5 years. Continuous treatment with proton-pump inhibitors for at least 5 years, immediate smoking cessation and follow-up gastroscopies are obligate for patients undergoing PD to avoid marginal ulcers and PMUs.
Sections du résumé
BACKGROUND
BACKGROUND
Perforated marginal ulcers (PMUs) are a feared long-term complication following pancreaticoduodenectomy (PD), which always require relaparotomy compared to marginal ulcers.
METHODS
METHODS
First, we performed a retrospective chart review for all patients who underwent PD from 2007-2016 to identify incidence and risk factors associated with PMUs. Second, we analyzed follow up gastroscopies in all patients undergoing PD from 2007-2011 to identify the overall incidence of marginal ulcers.
RESULTS
RESULTS
A total of 725 patients underwent PD in the retrospective study period. 17 patients (2.3%) suffered from PMU at a median postoperative time of 13 months. These patients were significantly younger (median age: 49 vs. 62 years; P=0.02) and suffered most often from chronic pancreatitis (P<0.001). Smoking and alcohol consumption were significantly more common (P=0.01 and P=0.023). An elevated level of carcinoembryonic antigen and chronic pancreatitis were identified as independent risk factors. Overall, 373 patients were enrolled for prospective analysis. Marginal ulcers occurred in 5-5.9% over a postoperative period of 5 years.
CONCLUSIONS
CONCLUSIONS
Continuous treatment with proton-pump inhibitors for at least 5 years, immediate smoking cessation and follow-up gastroscopies are obligate for patients undergoing PD to avoid marginal ulcers and PMUs.
Identifiants
pubmed: 33708556
doi: 10.21037/gs-20-763
pii: gs-10-02-739
pmc: PMC7944069
doi:
Types de publication
Journal Article
Langues
eng
Pagination
739-750Informations de copyright
2021 Gland Surgery. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/gs-20-763). The authors have no conflicts of interest to declare.
Références
Surg Endosc. 2015 May;29(5):1018-23
pubmed: 25159641
Eur J Clin Pharmacol. 2008 Oct;64(10):935-51
pubmed: 18679668
J Vis Exp. 2019 Sep 28;(151):
pubmed: 31609317
Br J Surg. 1989 Feb;76(2):173-6
pubmed: 2702454
Ther Adv Drug Saf. 2018 Nov 19;10:2042098618809927
pubmed: 31019676
Surg Clin North Am. 1966 Oct;46(5):1201-13
pubmed: 5924525
Ann Surg. 1992 Aug;216(2):142-5
pubmed: 1354435
Surg Gynecol Obstet. 1978 Jun;146(6):959-62
pubmed: 653575
World J Surg. 2011 Nov;35(11):2543-8
pubmed: 21882027
Br J Surg. 1990 Sep;77(9):968-74
pubmed: 2207587
HPB (Oxford). 2011 Jun;13(6):377-84
pubmed: 21609369
J Pak Med Assoc. 2007 Dec;57(12):595-9
pubmed: 18173042
Chirurg. 2015 Jun;86(6):519-24
pubmed: 25986674
Obes Surg. 2014 May;24(5):741-6
pubmed: 24347350
Acta Chir Belg. 2021 Feb;121(1):16-22
pubmed: 31433745
J Gastrointest Surg. 2014 Apr;18(4):690-700
pubmed: 24297652
J Hepatobiliary Pancreat Sci. 2020 Apr;27(4):171-181
pubmed: 31951086
J Gastrointest Surg. 2011 May;15(5):824-8
pubmed: 21347872
HPB (Oxford). 2014 Jan;16(1):40-5
pubmed: 23458209
Pancreas. 2020 Feb;49(2):208-215
pubmed: 32011522
JAMA. 1976 May 3;235(18):1975-9
pubmed: 56468
Surgery. 2020 Jul;168(1):67-71
pubmed: 32276736
J Hepatobiliary Pancreat Surg. 2000;7(2):193-7
pubmed: 10982613
Ann Surg. 1987 Dec;206(6):717-27
pubmed: 3689008
Endoscopy. 2011 Nov;43(11):950-4
pubmed: 21997722
Gastroenterology. 2017 Mar;152(4):706-715
pubmed: 28257716
Chin J Cancer Res. 2015 Aug;27(4):332-48
pubmed: 26361403